Valens GroWorks Corp (CSE:VGW, OTC:VGWCF) has sponsored the “The Future of Cannabis in Canada” report by Resonance Consultancy, in partnership with Insights West. Valens is a vertically-integrated provider of cannabis products for the global cannabis nutraceuticals market. The report covers cannabis consumption demands and trends in Canada since legalization in 2018.

“At Valens, we have a unique position in this growing cannabis market as a supply-chain partner and a co-packer of consumer goods for licensed producers across the country. We have a responsibility to help guide trends and provide quality products,” said Valens Executive VP of Strategy and Investments Everett Knight

In total, Valens and Resonance Consultancy surveyed 1,500 Canadians who had used cannabis in the past year, while Insights West surveyed 1,001 legal adults throughout Canada to give a broad view of the public’s perception of the plant. The report covers topics such as consumer demographics, consumption data, cannabis marketing campaigns, canna-tourism, sales and distribution among others.

Most importantly, the report also covers future trends for the market. Resonance Consultancy believes that cannabis will be in everything as cannabis companies and the Canadian government figure out what consumers want and what will be allowed to go to market over the next few years. Luxury cannabis brands will be a predominant trend moving forward, and women’s involvement in the industry will grow as they create cannabis lines and brands for other women.

“This report summarizes what it’s like living in Canada with legal cannabis, both through the eyes of a bystander and a consumer. As an emerging industry, breaking down consumer needs and desires has never been more necessary to sustain long-term market growth,” said Knight.

To read the full report, click here.

infoClick here to connect with Valens GroWorks Corp (CSE:VGW, OTC:VGWCF)  for an Investor Presentation. 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less